The Malaysian Reserve

Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans

Medicare beneficiaries with obesity or overweight will have access to Zepbound and orforglipron, if approved, at $50 a month  INDIANAPOLIS, Nov. 6, 2025 ...